Global Histone H3K27 Methylation Levels are Different in Localized and Metastatic Prostate Cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Global Histone H3K27 Methylation Levels are Different in Localized and Metastatic Prostate Cancer
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 30, Issue 2, Pages 92-97
Publisher
Informa UK Limited
Online
2011-12-08
DOI
10.3109/07357907.2011.636117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer
- (2011) Ann-Christin Schneider et al. BJU INTERNATIONAL
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease
- (2010) Ugur Deligezer et al. CLINICA CHIMICA ACTA
- Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies
- (2010) Neil Justin et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
- (2010) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Histone modifications and chromatin organization in prostate cancer
- (2010) Zhong Chen et al. Epigenomics
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy
- (2009) Li-Xin Zhou et al. ASIAN JOURNAL OF ANDROLOGY
- The value of EZH2, p27kip1, BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy
- (2009) Tineke Wolters et al. BJU INTERNATIONAL
- Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
- (2009) S. E. Elsheikh et al. CANCER RESEARCH
- Global levels of histone modifications predict prostate cancer recurrence
- (2009) Jörg Ellinger et al. PROSTATE
- Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non-Small Cell Lung Cancer
- (2008) A. Van Den Broeck et al. CLINICAL CANCER RESEARCH
- Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus
- (2008) Ching Tzao et al. MODERN PATHOLOGY
- Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
- (2008) Yongkun Wei et al. MOLECULAR CARCINOGENESIS
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
- (2008) Yutaka Kondo et al. NATURE GENETICS
- CpG Island Hypermethylation at Multiple Gene Sites in Diagnosis and Prognosis of Prostate Cancer
- (2008) Jörg Ellinger et al. UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started